Diseases of Pulmonary Vasculature

Latest Features

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

Evaluating diagnosis and treatment options for pulmonary arterial hypertension.

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

A 40-year-old woman presents with worsening shortness of breath after being treated with long-acting nifedipine for 2 years.

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

The diagnostic value of bronchoalveolar lavage in idiopathic pulmonary fibrosis is evaluated.

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Future clinical trials on pulmonary arterial hypertension should include patients from diverse racial and ethnic backgrounds.

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

The most common chronic respiratory morbidity affecting preterm neonates is bronchopulmonary dysplasia.

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

The risk of perioperative complications is increased by many factors in patients undergoing thoracic surgery.

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

James E. Loyd, MD, and Wendy Chung, MD, PhD, offer insight into the role of genetics in pulmonary arterial hypertension.

Latest News

PAH: eGFR Changes May Predict Survival, Hospitalizations

PAH: eGFR Changes May Predict Survival, Hospitalizations

A decrease in baseline estimated glomerular filtration rate in PAH may be a predictor of hospitalization and mortality.

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Catheter-directed thrombolysis vs systemic thrombolysis strategies show different risk outcomes for patients with intermediate-risk pulmonary embolism.

Pediatric Pulmonary Embolism: 9 Predictors Identified

Pediatric Pulmonary Embolism: 9 Predictors Identified

Several clinical predictors of pediatric pulmonary embolism have been identified.

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

Use of riociguat may be considered for severe pulmonary arterial hypertension in pediatric patients.

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

Balloon pulmonary angioplasty may improve hemodynamics in patients with CTEPH.

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.

Pulmonary Artery Compliance Predictive of Mortality in PAH With Adult CHD

Pulmonary Artery Compliance Predictive of Mortality in PAH With Adult CHD

Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized glycopyrrolate improves lung function and patient-reported outcomes in patients with moderate to very severe COPD.

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right ventricular base/apex ratio during systole can discriminate between types of pulmonary hypertension.

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Quality of life in patients with idiopathic pulmonary fibrosis can be significantly affected by depression and anxiety.

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

Patients with saddle and nonsaddle pulmonary embolism have similar short-term outcomes, despite more serious symptoms being present in saddle pulmonary embolism.

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

The European Society of Cardiology and the European Society for Vascular Surgery have developed new guidelines on the diagnosis and treatment of peripheral arterial disease.

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

Patients with high-risk obstructive sleep apnea are almost 4 times more likely to have postoperative complications vs patients with low-risk obstructive sleep apnea.

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

People with obstructive sleep apnea could have a higher risk for hypercoagulability.

Sign Up for Free e-Newsletters